Covidien PLC (COV): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Covidien ( COV) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.4%. By the end of trading, Covidien rose $0.65 (1.1%) to $60.90 on average volume. Throughout the day, 2,326,983 shares of Covidien exchanged hands as compared to its average daily volume of 2,629,800 shares. The stock ranged in a price between $60.10-$61.12 after having opened the day at $60.23 as compared to the previous trading day's close of $60.25. Other companies within the Health Services industry that increased today were: Bovie Medical Corporation ( BVX), up 11.9%, Arrhythmia Research Technology ( HRT), up 11.7%, Rockwell Medical ( RMTI), up 6.0% and Solta Medical ( SLTM), up 5.9%.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Covidien has a market cap of $28.5 billion and is part of the health care sector. Shares are up 4.3% year to date as of the close of trading on Friday. Currently there are 13 analysts that rate Covidien a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Stereotaxis ( STXS), down 12.7%, Dynatronics Corporation ( DYNT), down 10.9%, Dehaier Medical Systems ( DHRM), down 8.6% and Pingtan Marine Enterprise ( PME), down 7.1% , were all laggards within the health services industry with Tenet Healthcare ( THC) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Trump, Trade Wars, General Electric, 'Jurassic World' - 5 Things You Must Know

Trump, Trade Wars, General Electric, 'Jurassic World' - 5 Things You Must Know

Boeing Slides as China Premier Li Says Willing to Continue Talks With Airbus

Boeing Slides as China Premier Li Says Willing to Continue Talks With Airbus

US Auto Tariffs Would Hit Global Industry Ratings; Ford & GM Vulnerable- Moody's

US Auto Tariffs Would Hit Global Industry Ratings; Ford & GM Vulnerable- Moody's

Futures Fall on Further Trade News and 4 Other Stories to Watch Monday Morning

Futures Fall on Further Trade News and 4 Other Stories to Watch Monday Morning

Stocks Weaken Around The World as Trump Opens New Fronts in Global Trade War

Stocks Weaken Around The World as Trump Opens New Fronts in Global Trade War